Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial

التفاصيل البيبلوغرافية
العنوان:	Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial
المؤلفون:	Krug, Lee M, Kindler, Hedy L, Calvert, Hilary, Manegold, Christian, Tsao, Anne S, Fennell, Dean, Öhman, Ronny, Plummer, Ruth, Eberhardt, Wilfried E E, Fukuoka, Kazuya, Gaafar, Rabab M, Lafitte, Jean-Jacques, Hillerdal, Gunnar, Chu, Quincy, Buikhuisen, Wieneke A, Lubiniecki, Gregory M, Sun, Xing, Smith, Margaret, Baas, Paul
المصدر:	In The Lancet Oncology April 2015 16(4):447-456
قاعدة البيانات:	ScienceDirect

كن أول من يترك تعليقا!